Citadel Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $65.8K | Sell |
|
|||||
|
2024
Q4 | $733K | Sell |
|
|||||
|
2024
Q3 | $1.99M | Buy |
|
|||||
|
2024
Q2 | $1.74M | Buy |
|
|||||
|
2024
Q1 | $792K | Buy |
|
|||||
|
2023
Q4 | $528K | Sell |
|
|||||
|
2023
Q3 | $1.75M | Sell |
|
|||||
|
2023
Q2 | $5.54M | Sell |
|
|||||
|
2023
Q1 | $5.3M | Buy |
|
|||||
|
2022
Q4 | $2.92M | Buy |
|
|||||
|
2022
Q3 | $1.67M | Buy |
|
|||||
|
2022
Q2 | $1.84M | Sell |
|
|||||
|
2022
Q1 | $11.2M | Sell |
|
|||||
|
2021
Q4 | $14.9M | Buy |
|
|||||
|
2021
Q3 | $3.49M | Buy |
|
|||||
|
2021
Q2 | $1.24M | Buy |
|
|||||
|
2021
Q1 | $248K | Sell |
|
|||||
|
2020
Q4 | $7.03M | Buy |
|